This week’s newsletter covers California’s hemp THC regulatory crackdown, a rise in pediatric THC poisonings, declining cannabis sales in Colorado, and new scientific research on vaporized cannabis for migraines, CBG’s therapeutic potential, the entourage effect, and CBD for anxiety disorders.
Noteworthy Read
Why Did California Kill a Booming Hemp THC Industry? (Los Angeles Times)
This article explores how California’s regulatory crackdown on hemp-derived THC products disrupted a thriving industry, raising questions about balancing public safety and economic opportunities.
More Noteworthy Reading
Pediatric Marijuana Poisonings Linked to THC-Infused Products (Channel 9)
A report highlights the alarming rise in pediatric marijuana poisonings, primarily tied to THC-infused edibles, underscoring the importance of responsible packaging and education.
Marijuana Sales Keep Falling (Colorado Sun)
Colorado’s marijuana industry faces declining sales, sparking concerns about market saturation and competition from neighboring states with lower tax rates.
Research Round-Up
Preprint: Vaporized Cannabis (CBD & THC) Effective for Acute Migraine (PubMed)
A preprint study demonstrates that vaporized cannabis containing both CBD and THC significantly alleviates acute migraine symptoms, offering an alternative therapeutic approach.
Read more
View more in Endocannabinoid System
Review of CBG’s Molecular Mechanisms & Therapeutic Potential (Molecules)
This review highlights cannabigerol (CBG)’s therapeutic potential, including anti-inflammatory, neuroprotective, and antibacterial properties, making it a promising cannabinoid for medical use.
Read more
View more in Endocannabinoid System
The Entourage Effect in Medical Cannabis Products (Pharmaceuticals)
A study examines the “entourage effect,” emphasizing how interactions between cannabinoids and terpenes enhance the therapeutic efficacy of medical cannabis products.
Read more
View more in Endocannabinoid System
CBD for Anxiety Disorders (PubMed)
Recent research confirms the efficacy of CBD in reducing symptoms of various anxiety disorders, with potential implications for long-term treatment strategies.
A heartfelt thank you to all of the CBD brands whose generous support empowers Project CBD to bring you the latest research and reporting on plant medicine each and every week.
